Wednesday, December 5, 2018 12:33 AM
PLAINVILLE, Mass.—Hilco Vision
announced it has acquired Tucson, Ariz.-based ophthalmic supplies company Eye Care and Cure
(ECC) effective Nov. 30. Ross Brownlee, CEO of Hilco Vision noted, “Eye Care and Cure has built a superb reputation addressing the pharmaceutical and diagnostic needs of its customers over many years through its subject matter expertise, breadth of line, quality of service and desire to simplify the buying experience for its customers—common qualities to the aspirations of the Wilson Ophthalmic division and Hilco Vision as a group. I am confident the value proposition we have for our combined customer base is really enhanced by this acquisition and look forward to building further on this new platform.”
Wednesday, December 5, 2018 12:27 AM
PADUA, Italy—Kering Eyewear
has announced the launch of its newly designed institutional website, “keringeyewear.com,” which went live on Dec. 4, 2018. According to the company, the website will allow users to stay updated on Kering Eyewear’s latest news and collection as well as to consult the company’s career opportunities and open positions. Along with visitors to the website being able to view styles and digital campaigns belonging to the 15 brands designed, developed and distributed by Kering Eyewear, the site also features a “Store Locator” for clients to find the closest authorized stores for their favorite brands from Kering Eyewear’s portfolio.
Thursday, November 8, 2018 12:24 AM
, a nationwide doctor alliance group for independent eyecare professionals, hosted its inaugural Strategic Partner Summit here in mid-October. The invitation-only event brought together senior leadership from integral industry vendor partners to discuss the inevitable changes impacting the industry and to explore solutions on how the group, collectively, could best serve their mutual customers and help support the future of independent optometry, according to an announcement. Jamie Hughes, PECAA’s general manager, led the summit meeting, and Bart Foster, managing director of Sanitas Advisors
, acted as the facilitator.
Wednesday, October 24, 2018 12:18 AM
PHOENIX—Eyewear by ROI
and Karen Kane
have extended their eyewear license through 2022. Eyewear by ROI designs, manufactures and distributes Karen Kane Eyewear through the U.S., Canada, Mexico, Europe, Asia and Australia. “We are excited to be able to continue to represent Karen Kane in the eyewear category,” said John Alofs, founder and CEO, Eyewear by ROI. Lonnie Kane, president of the Karen Kane Company added, "We are thrilled to renew our agreement and extend our partnership with Eyewear by ROI. They are fantastic collaborators. Working with them has been a great experience, and we look forward to continuing to build the Karen Kane brand with them.
Tuesday, October 23, 2018 12:27 AM
MILAN—Third quarter net sales for Luxottica Group S.p.A. (MTA: LUX) grew by 3.5 percent at constant exchange rates and 2.9 percent at current rates, driven by retail and e-commerce, the company reported.
Tuesday, October 16, 2018 12:21 AM
BELLPORT, N.Y.—OptiSource International
has acquired the eyeglass case division of Amityville, N.Y. based New York Eye
. The terms of the transaction were not announced. New York Eye will continue to market value-priced, branded frames. OptiSource currently offers a line of high quality eyeglass cases that can be personalized with practice information. “The addition of the New York Eye value-line of eyeglass cases allows OptiSource to expand our offering at multiple price points to better serve our customer base,” said Daryl Squicciarini, president of OptiSource.
Friday, October 12, 2018 12:21 AM
PITTSBURGH—Paws N Claws Eyewear
, the philanthropic, animal-friendly optical company, has expanded to Canada with Paws N Claws Eyewear Canada. With the company’s new marketing director, Brian Heap, Paws N Claws will continue to give back with its philanthropic partnership with the Canadian Federation of Humane Societies (CFHS) and Humane Canada. Through its new partnership with CFHS, Paws N Claws will donate 3 percent to 5 percent of net sales.
Monday, September 24, 2018 12:18 AM
NEW YORK—Marchon Eyewear, Inc.
and Cutler and Gross Ltd.
have announced that they have entered into a long-term exclusive agreement for the distribution of Cutler and Gross optical and sun product throughout the U.S. This agreement leverages the unique scale and expertise of Marchon Eyewear’s U.S. distribution network and its increased focus on the luxury segment of the market.
Friday, September 14, 2018 12:21 AM
CARROLLTON, Texas—A&A Optical
has announced an exclusive licensing agreement for the design, development and distribution of RACHEL Rachel Roy
(RRR) eyewear. The agreement includes worldwide distribution of women’s ophthalmic eyewear and sunglasses. RACHEL Rachel Roy will debut ophthalmic eyewear March 2019 at Vision Expo East.
Thursday, September 13, 2018 12:24 AM
FORT WORTH, Texas—The “new” Alcon
that emerges from a planned spin-off from Novartis
(NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session.
Wednesday, September 12, 2018 12:24 AM
FORT WORTH, Texas—Eyevance Pharmaceuticals
, a Fort Worth-based pharmaceutical company, has acquired the Freshkote family of lubricant eye drops from Focus Laboratories
. Under the terms of the agreement, Eyevance acquired Freshkote and all its formulations, including the preservative-free, multi-dose bottle and single-unit vials, to market and commercialize worldwide. The financial terms of the agreement were not disclosed. “The acquisition of the Freshkote franchise represents an important business milestone for Eyevance, which is actively building a portfolio of impactful and innovative eyecare products, focused on the anterior segment of the eye,” said Jerry St. Peter, CEO and director, Eyevance.
Monday, September 10, 2018 12:18 AM
PLAINVILLE, Mass.—Hilco Vision
has announced that Croakies
has expanded its relationship with all-pro tight end for the Cincinnati Bengals, Tyler Eifert, leading into the 2018-2019 football season. “This elevated partnership sees Eifert formally endorsing the Croakies brand throughout his professional and everyday life,” the company stated. As a part of this partnership, Eifert will mix product endorsement with digital content, brand campaign support and exclusive product introductions. “Honestly, this was easy for me,” Eifert said.
Thursday, September 6, 2018 12:21 AM
WATERTOWN, Mass.—EyePoint Pharmaceuticals
(NASDAQ:EYPT), a specialty biopharmaceutical company working to develop innovative ophthalmic products, reported Wednesday that the Centers for Medicare and Medicaid Services (CMS) has approved transitional pass-through status and reimbursement through a C-code for Dexycu (dexamethasone intraocular suspension) 9%. Dexycu is an FDA-approved product for treating postoperative inflammation. It is administered as a single intraocular dose at the end of ocular surgery, according to EyePoint’s announcement. The code, C9034, will become effective Oct. 1, 2018, the company said.
Wednesday, September 5, 2018 12:18 AM
FARMINGTON, Utah—Vista Outdoor Inc.
has announced the completion of the divestiture of the legal entities operating its Bolle, Cebe and Serengeti eyewear brands. “Completing the sale of our Eyewear brands is a positive step in our strategic transformation plan,” said Chris Metz, Vista Outdoor’s chief executive officer. “We believe this is a mutually beneficial arrangement for both parties, and we are excited that the buyer will help these iconic brands thrive.” In November 2017, the company announced its intention to sell the eyewear business as VMAIL reported
Thursday, August 30, 2018 12:18 AM
on Wednesday announced an “immediate, voluntary market withdrawal” of the CyPass Micro-Stent from the global market. The company said the decision is based, in part, on its “uncompromising commitment to patient safety.” In addition, Alcon advised surgeons to immediately cease further implantation with the CyPass Micro-Stent and to return any unused devices to Alcon. “This decision and corresponding recommendation is based on an analysis of five-year post-surgery data from the COMPASS-XT long-term safety study,” the announcement noted. Alcon, the eyecare unit of Novartis, is expected to become an independent publicly traded company after a spinoff by its corporate parent in early 2019, as VMAIL